Qiming Venture Partners

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore, and a global arm through Qiming Venture Partners USA. It manages multiple funds and invests in early and growth-stage companies across technology, information technology, healthcare, new consumer sectors, AI, robotics, semiconductors, software and digital health. The firm emphasizes a hands-on approach, often taking board seats and providing operational guidance to help CEOs scale and reach exits. Through its investments, it has backed hundreds of companies and supported numerous IPOs and M&A outcomes, with unicorns among its portfolio, illustrating breadth and depth across China and international markets.

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Nan Chen

Principal

Chen Liwen

Associate

David Chu

Partner

Isaac Ciechanover

Partner

Phillip DiGiacomo Ph.D

Principal

Phil DiGiacomo

Principal

Anna French Ph.D

Managing Partner

Yuxin Fu

Associate

Jinda Gao

Principal

Robert Headley

Partner

Maykin Ho

Venture Partner

William Hu

Managing Partner

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Duane Kuang

Managing Partner

Nisa Leung

Managing Partner

Lisa Li

Investor

Dingzheng Li

Vice President

Bin Liu

Associate

Jing Liu

Associate

Chang Liu

Associate

Biao LU

Associate

Shuo Mao

Vice President

Will McConnell

Principal

Mark McDade

Partner

Gary Rieschel

Managing Partner

James Shen

Venture Partner

Motao Sun

Associate

Amy Tang

Venture Partner

Yi Tang

Vice President

Xin Wang

Investor

Shiyu Wang

Partner

Bonnie Wang

Partner

Rachel Wang

Venture Partner

James Wang

Venture Partner

Jing Wu

Partner

Xu Gillian

RMB funds CFO

Kuantai Yeh

Partner

Peter Yin

Principal

Janet Yu

Partner

Oscar Zhang

Principal

Zhang Ao

Executive Director

Zhiyuan Zhou

Investor

Alex Zhou

Managing Partner

Yafeng Zhou

Associate

Zhifeng Zhou

Managing Partner

Yiqing Zhu

Associate

Past deals in Artificial Intelligence

iflybuds

Seed Round in 2025
Vision Intelligence is a AI smart hardware company that manufactures and sells interactive intelligence based electronic consumer products.

TARS

Angel Round in 2025
Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.

Force Inspiration

Angel Round in 2025
Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robot manufacturing and sales.

MiGuo AI

Angel Round in 2025
Miguo AI enhances artificial intelligence in various industries and transforms visual content creation.

Xi'an Dunbo Medical Equipment

Series A in 2025
Xi'an Dunbo Medical Equipment focuses on the research, development, and production of AI medical devices. The products currently under development are cardiac pacemakers and brain pacemakers, Cardiac defibrillators. Self-developed products include chips, hardware circuits, software application systems, and structural materials.

StepStar

Series B in 2024
The goal of Stepstar is to "Ten Times the Possibility of Everyone" through Intelligent Step. Step Star firmly creates its own super model and actively uses important resources like

Zhipu AI

Venture Round in 2024
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Matwings Technology

Series A in 2024
Matwings is a biotechnology company that employs artificial intelligence to design optimized proteins. It collaborates with major pharmaceutical firms to develop innovative drugs targeting challenging targets.

Tianhu Technology

Series A in 2024
Tianhu Technology provides drug research and development services through independent collaborative closed-loop iterations, deeply integrating AI solutions with the drug development and production process. Tianhu Technology is an innovative drug R&D company that offers high-throughput phenotypic screening and physical computing technology, as well as AI solutions that are deeply integrated into the drug R&D process.

Bioyond Tech

Series A in 2024
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Zhipu AI

Series D in 2024
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Infinigence

Series A in 2024
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.

TandemAI

Series C in 2024
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.

Thorough Future

Series A in 2024
Thorough Future specializes in integrating advanced technology into medical care. It focuses on enhancing diagnostic services' accuracy and efficiency for clinical medicine and providing personalized treatment recommendations, particularly for cancer patients.

Shengshu Technology

Venture Round in 2024
Shengshu Technology specializes in developing generative AI infrastructure for multi-modal large-scale models. It integrates text, images, videos, 3D data, and other modalities to create innovative AI solutions.

Zhipu AI

Series B in 2024
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Shengshu Technology

Seed Round in 2024
Shengshu Technology specializes in developing generative AI infrastructure for multi-modal large-scale models. It integrates text, images, videos, 3D data, and other modalities to create innovative AI solutions.

Pinnacle Medicines

Series A in 2024
Pinnacle Medicines is a biotechnology company based in Doylestown, Pennsylvania. It specializes in peptide drug discovery, utilizing AI-based tools to develop safe and effective therapeutics for unmet medical needs.

Leapstack

Series C in 2023
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.

ABUP

Series B in 2023
ABUP specializes in over-the-air (OTA) technology solutions for the automotive and Internet of Things (IoT) sectors. The company delivers a range of products that include firmware upgrades, software upgrades, and cloud diagnosis services tailored for vehicles and IoT devices. By leveraging artificial intelligence and big data, ABUP enables its clients to enhance their offerings, ensuring that products remain current and provide users with a customized experience. The company's solutions are designed to support original equipment manufacturers (OEMs) in managing OTA systems effectively, facilitating continuous innovation and personalized service within the rapidly evolving landscape of connected technologies.

Yanyin Technology

Seed Round in 2023
Yanyin Technology provides AI solutions and scientific research collaboration platforms for biomedical field.

Prime Lifescience

Seed Round in 2023
Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through digital technology innovation and the extensive application of artificial intelligence. Prime Lifescience offers a digital smart health community, an intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions environment, ultimately benefiting the healthcare sector through improved data-driven insights and collaboration.

Infinigence

Series A in 2023
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.

Shennapsi Artificial Intelligence Technology

Series A in 2023
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Huimei Technology

Series D in 2023
Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.

Inexbot

Series A in 2023
iNexBot is a developer and manufacturer specializing in robot motion controllers and industrial robot intelligence technology. The company focuses on the research and development of advanced solutions for various sectors, including industrial robotics, collaborative robotics, semiconductors, healthcare automation, and automotive electronics. iNexBot provides essential hardware and software components, including control systems, robot cabinets, and fieldbus IO, to support robot manufacturers in enhancing their robotic products. Additionally, the company is involved in developing machine vision technology and laser seam tracking technology, further expanding its offerings in the robotics field.

Jiiov Technology

Venture Round in 2023
Jiiov Technology is a provider of biometric recognition solutions specializing in fingerprint identification products tailored for intelligent terminals. The company develops advanced algorithms for artificial intelligence-driven fingerprint recognition, including innovative extreme finger fingerprint algorithms. In addition to algorithm development, Jiiov Technology focuses on professional sensor design, optical design, module design, and specialized computing. This comprehensive suite of offerings enables effective law and software integration, enhancing the fingerprint capabilities of intelligent terminal devices.

Solo Music

Series B in 2023
Solo Music is an AI-based music education platform that provides online education services for several musical instruments.

Zhipu AI

Series B in 2023
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Thorough Future

Series A in 2023
Thorough Future specializes in integrating advanced technology into medical care. It focuses on enhancing diagnostic services' accuracy and efficiency for clinical medicine and providing personalized treatment recommendations, particularly for cancer patients.

HOUMO.AI

Series A in 2023
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that deliver substantial computing power while maintaining low energy consumption, thereby enabling enterprises to create advanced AI-integrated electronics and intelligent robotics products at competitive prices. By leveraging disruptive technologies, Houmo.AI aims to address the growing demand for computing power in the realm of true artificial intelligence, striving to revolutionize the industry with its innovative solutions.

Zeen Health

Series A in 2023
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

Bioyond Tech

Series A in 2023
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Qianshou

Series A in 2023
Qianshou is a dating application that helps to find the right partner for life by using artificial matchmaker service.

Deepway

Series A in 2023
Deepway is a manufacturer of smart vehicles focused on providing intelligent driving solutions for the truck freight market. The company specializes in heavy-duty trucks characterized by low wind resistance bodies and advanced intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design, which operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.

Frontis

Angel Round in 2023
Frontis is a technology company that specializes in artificial intelligence solutions tailored for businesses in the fast-moving consumer goods, consumer electronics, and beauty sectors. The company develops demand planning software that assists clients in forecasting product demand, enabling them to align their offerings with consumer needs effectively. Additionally, Frontis provides comprehensive services, including 3C product planning, performance monitoring for product launches, and digital transformation solutions. By leveraging advanced technology, Frontis aims to enhance the connection between businesses and their consumers, delivering valuable insights that drive informed decision-making and strategic planning.

TandemAI

Series A in 2023
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.

Biotree Technology

Series A in 2023
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Shennapsi Artificial Intelligence Technology

Series A in 2022
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Thorough Future

Series A in 2022
Thorough Future specializes in integrating advanced technology into medical care. It focuses on enhancing diagnostic services' accuracy and efficiency for clinical medicine and providing personalized treatment recommendations, particularly for cancer patients.

Deepway

Series A in 2022
Deepway is a manufacturer of smart vehicles focused on providing intelligent driving solutions for the truck freight market. The company specializes in heavy-duty trucks characterized by low wind resistance bodies and advanced intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design, which operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Biren Technology

Series B in 2022
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.

Biotree Technology

Series A in 2022
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Ashermed

Series B in 2022
Ashermed is a provider of contract research organization (CRO) services specifically designed for medical companies. The company emphasizes the integration of advanced technologies, such as Internet technology, big data, and artificial intelligence, to enhance the drug development process. By leveraging these technologies, Ashermed aims to shorten the clinical data development cycle and improve the quality of research outcomes, ultimately reducing research and development costs for its clients. Their offerings include CRO services, site management organization (SMO) support, patient recruitment, and digital platform assistance, all tailored to facilitate the needs of the medical industry.

Rhino Federated Computing

Venture Round in 2022
The value of connecting disparate datasets is immense, yet much of this potential remains untapped. Imagine the transformative possibilities: pharmaceutical companies sharing data to design better drugs and evaluate their real-world value, hospitals and HMOs diagnosing rare diseases faster, or financial institutions collaborating to combat financial crime. Rhino Federated Computing makes this vision a reality. Our federated computing platform, powered by advanced edge-computing and federated learning technologies, enables organizations to train and deploy AI models on massive, distributed datasets—without sharing sensitive information or compromising data privacy and sovereignty. This breakthrough approach was pioneered by our co-founder and CEO, Dr. Ittai Dayan, a recognized leader in the field whose work includes a landmark Nature Medicine publication in 2021.

HOUMO.AI

Series A in 2022
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that deliver substantial computing power while maintaining low energy consumption, thereby enabling enterprises to create advanced AI-integrated electronics and intelligent robotics products at competitive prices. By leveraging disruptive technologies, Houmo.AI aims to address the growing demand for computing power in the realm of true artificial intelligence, striving to revolutionize the industry with its innovative solutions.

Vistel

Series B in 2022
Vistel is a technology company established in 2016 by Sun Yuhui and Ding Dayong, specializing in artificial intelligence applications within the medical field. The firm develops AI-driven ophthalmic medical imaging technology designed to enhance the diagnosis of eye diseases. By employing advanced diagnostic systems that utilize computer vision processing and sophisticated image annotation, Vistel aims to provide medical practitioners with the tools necessary to digitally analyze and manage patients' ocular conditions effectively.

Jiiov Technology

Series A in 2022
Jiiov Technology is a provider of biometric recognition solutions specializing in fingerprint identification products tailored for intelligent terminals. The company develops advanced algorithms for artificial intelligence-driven fingerprint recognition, including innovative extreme finger fingerprint algorithms. In addition to algorithm development, Jiiov Technology focuses on professional sensor design, optical design, module design, and specialized computing. This comprehensive suite of offerings enables effective law and software integration, enhancing the fingerprint capabilities of intelligent terminal devices.

Zhipu AI

Series B in 2022
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Prime Lifescience

Seed Round in 2022
Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through digital technology innovation and the extensive application of artificial intelligence. Prime Lifescience offers a digital smart health community, an intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions environment, ultimately benefiting the healthcare sector through improved data-driven insights and collaboration.

Axera

Series A in 2022
Axera is a high-tech semiconductor company specializing in the development of advanced artificial intelligence (AI) System-on-Chips (SoCs) for computer applications. The company's flagship product is an AI chip designed to excel in visual processing tasks, offering superior performance at low power consumption and latency, while maintaining high integration capabilities. This enables clients to perform real-time video analysis on devices, capture high-quality videos, and integrate multiple cameras efficiently with reduced costs.

Tungee

Series B in 2021
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

Gemsouls

Series A in 2021
Gemsouls is an artificial intelligence company that develops technology to create virtual characters and facilitate their interactions with the real world. The platform aims to offer fans a novel way to engage with their favorite characters, enabling lasting connections with both fictional and real-life figures. By leveraging AI, Gemsouls enhances the experience of users, allowing them to stay connected to those they cherish, whether they are beloved characters from stories or significant individuals in their lives.

DP Technology

Series B in 2021
DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.

Frontis

Seed Round in 2021
Frontis is a technology company that specializes in artificial intelligence solutions tailored for businesses in the fast-moving consumer goods, consumer electronics, and beauty sectors. The company develops demand planning software that assists clients in forecasting product demand, enabling them to align their offerings with consumer needs effectively. Additionally, Frontis provides comprehensive services, including 3C product planning, performance monitoring for product launches, and digital transformation solutions. By leveraging advanced technology, Frontis aims to enhance the connection between businesses and their consumers, delivering valuable insights that drive informed decision-making and strategic planning.

Bioyond Tech

Seed Round in 2021
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Zeen Health

Venture Round in 2021
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

Lingyi Zhihui

Series B in 2021
Zuoshouyisheng's AI ​​doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.

HOUMO.AI

Seed Round in 2021
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that deliver substantial computing power while maintaining low energy consumption, thereby enabling enterprises to create advanced AI-integrated electronics and intelligent robotics products at competitive prices. By leveraging disruptive technologies, Houmo.AI aims to address the growing demand for computing power in the realm of true artificial intelligence, striving to revolutionize the industry with its innovative solutions.

WeRide

Series C in 2021
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.

Insilico Medicine

Series C in 2021
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Tungee

Series C in 2021
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

CastBox

Series C in 2021
Founded in 2016, CastBox operates a global spoken audio platform offering personalized recommendations for listeners of podcasts, on-demand radio, and audiobooks. Its application is accessible across mobile devices, desktops, and smart home devices, with offices in Beijing, Hong Kong, and San Francisco.

Xizi Education

Series A in 2021
Xizhi Education (Beijing Xizi Education Technology Co., Ltd.) is a leading enterprise in artificial intelligence empowerment education. The headquarters is located in Zhizhi Street, Zhongguancun, which is known as the “China Silicon Valley”. As one of the key incubators of Tsinghua University, from the aspects of policy, capital and talents, it has been strongly supported by Tsinghua's three innovation and entrepreneurship platforms iCenter, Chuang+ and xlab, and won the honor of Zhongguancun High-tech Enterprise.

Unisound

Series D in 2021
Unisound is a Chinese mobile internet startup focusing on intelligent voice and speech processing technologies. Founded in June 2012, the company owns speech recognition technologies with independently developed intellectual property. Leveraging cloud computing and mobile internet, it launched middleware and cloud platforms for speech recognition services, providing internet enterprises and users with professional speech recognition services. Its core technology team comprises members from major companies, universities, and research institutes, with over 80% holding doctoral degrees and more than 10 years of R&D experience in voice recognition.

Axera

Seed Round in 2021
Axera is a high-tech semiconductor company specializing in the development of advanced artificial intelligence (AI) System-on-Chips (SoCs) for computer applications. The company's flagship product is an AI chip designed to excel in visual processing tasks, offering superior performance at low power consumption and latency, while maintaining high integration capabilities. This enables clients to perform real-time video analysis on devices, capture high-quality videos, and integrate multiple cameras efficiently with reduced costs.

Hangzhou Weier

Series B in 2021
Hangzhou Weier Technology Co., Ltd, also known as Weier Science, specializes in the design and development of robots and software that enhance human-machine interaction. Founded in 2016 and headquartered in Hangzhou, China, the company operates within the augmented and virtual reality sectors. Weier Technology focuses on artificial intelligence and natural language processing to create customer service robots that assist e-commerce platforms. These robots can answer customer inquiries, generate customer profiles, and analyze data to improve service delivery, ultimately helping businesses better understand and engage with their clients.

WeRide

Series B in 2021
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.

Vistel

Series B in 2021
Vistel is a technology company established in 2016 by Sun Yuhui and Ding Dayong, specializing in artificial intelligence applications within the medical field. The firm develops AI-driven ophthalmic medical imaging technology designed to enhance the diagnosis of eye diseases. By employing advanced diagnostic systems that utilize computer vision processing and sophisticated image annotation, Vistel aims to provide medical practitioners with the tools necessary to digitally analyze and manage patients' ocular conditions effectively.

TutorEva

Venture Round in 2021
TutorEva is an educational technology company that has developed an online application enabling users to scan arithmetic problems and receive solutions in various formats, including text, illustrations, and voice instructions. Utilizing artificial intelligence, the platform not only provides answers but also offers tutoring assistance, allowing students to better understand and solve mathematical challenges. Through its innovative approach, TutorEva aims to enhance the learning experience and support users in their academic pursuits.

Shukun

Series B in 2020
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Tungee

Series B in 2020
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

New Horizon Health

Series E in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Biren Technology

Series A in 2020
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.

Shukun

Series B in 2020
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

New Horizon Health

Series D in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

NVX Clouds Tech

Series A in 2020
NVX Clouds Tech is an artificial intelligence security computing company focused on data privacy protection. It utilizes unique privacy computing technology to fully protect local and cloud data privacy and security through the Cing Weixin privacy cloud computing platform and all-in-one product line. It also provides solutions for the protection of big data security and commercial secrets in finance. The company aims to build a privacy computing platform for big data, separate the ownership, management, and use rights of the data, fully realize the flow of data, and promote the fourth industrial revolution.

Genius

Series B in 2019
Genius, founded in February 2017, specializes in K12 artificial intelligence education. The company develops a STEAM education curriculum and technology, designing courses and projects that cover digital modeling, robotics, programming, and entrepreneurship. These resources are intended for educators to implement in their classrooms, empowering students to engage with and contribute to future technological innovations.

Club Factory

Series D in 2019
Club Factory is an online shopping platform that facilitates cross-border e-commerce by connecting consumers directly with manufacturers. By leveraging big data and artificial intelligence, the company scans the internet to identify factories that sell products on various platforms such as Wish, eBay, and Amazon. This allows Club Factory to compare prices from multiple sources, ultimately presenting customers with the lowest available prices. In addition to enhancing the shopping experience for consumers, the company also provides supply chain management solutions for enterprises, enabling them to optimize their operations and improve cost efficiency.

TigerGraph

Series B in 2019
TigerGraph Inc. is a technology company that specializes in graph analytics and databases. Founded in 2012 and headquartered in Redwood City, California, with additional offices in Shanghai, London, and Munich, the company offers a platform that combines native graph storage and computing with real-time updates. This platform is designed to facilitate advanced analytics and machine learning on connected data, enabling applications such as fraud detection, anti-money laundering, entity resolution, and cybersecurity. TigerGraph's technology allows enterprises to transform complex data into a network of objects and relationships, uncovering hidden patterns and actionable insights. The company's tools support ad-hoc and interactive analytics, making it a vital resource for organizations seeking to enhance their relationship analysis capabilities.

Insilico Medicine

Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Huimei Technology

Series C in 2019
Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.

Tungee

Series B in 2019
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

New Horizon Health

Series C in 2019
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Mech-Mind Robotics

Series A in 2019
Mech-Mind Robotics Technologies is a prominent manufacturer based in Beijing, China, specializing in hardware and software solutions for the logistics industry. Founded in 2016, the company produces advanced smart cameras, including the Mech-Eye series, which are designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind also develops AI-powered software that enables robotic cameras to identify and process objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in tackling complex automation challenges, including bin picking and assembly tasks, thereby enhancing operational efficiency in the e-commerce and logistics sectors. The company further extends its reach with an office in Munich, Germany, and a sales office in Shanghai, China.

Emergen

Series B in 2019
Emergen is a developer and manufacturer specializing in intelligent robotics and manufacturing solutions, founded by Dr. Gan Middle School, a distinguished expert in the national "Thousand Talents Program." The company focuses on creating high-performance robotic products with independent intellectual property rights, aiming to disrupt foreign monopolies in key robotic components. Emergen has developed two core technologies: a distributed intelligent robot controller and a group intelligence network controller. These innovations are integral to the construction of smart factories, enabling closed-loop control of process data, traceability of quality information, and comprehensive management of intelligent logistics. The company is committed to advancing the field of intelligent manufacturing, providing solutions that enhance efficiency and productivity across various industrial applications.

WeRide

Series A in 2019
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.

ABC Fintech

Series B in 2018
ABC Fintech provides AI-driven cloud services for financial professionals. Its products, Modeling.ai and Eversight.ai, can improve the efficiency of how equity research and investment decisions are made in financial institutions, as well as to predict future trend. The company was founded in 2016 by Yongzhi Yang, who is also the founder and CEO of MoboTap Inc, the company behind Dolphin Browser. So far, ABC Fintech has raised a total of $60 million USD from Qiming Venture Partners, Source Code Capital, SIG Asia Investment, Welight Capital, and MindWorks Ventures.

Yi Technology

Series D in 2018
YI Technology is a prominent international developer of advanced imaging technologies, specializing in smart, wearable, and mobile video products. The company is recognized for its innovative contributions to the imaging sector, including the launch of the first action camera capable of recording 4K60 video with extended recording times. YI Technology's product lineup encompasses a variety of devices such as smart home cameras, sports cameras, driving recorders, mirrorless cameras, smart retail boxes, and face capture machines. The company leverages cutting-edge technologies, including computer vision algorithms, deep learning, and advanced face recognition systems, to deliver high-performance, high-quality vision products at competitive prices. Through its focus on intelligent electronic products, YI Technology enables clients to enhance their imaging experiences with sophisticated technology.

Eigen

Series B in 2018
Eigen Technologies, Inc. is a provider of artificial intelligence services based in Hangzhou, China. The company focuses on applying advanced AI technologies across various business domains, emphasizing natural language understanding, knowledge graphs, and deep learning. By leveraging these technologies, Eigen aims to enhance user experiences and drive innovation, offering industries solutions for big data analysis rooted in artificial intelligence.

WeRide

Series A in 2018
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.

Tungee

Series A in 2018
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

AI Prime

Series A in 2018
AI-Prime is a company based in Shanghai, China, that specializes in artificial intelligence-driven safety solutions for industrial environments. It offers a cloud-based software-as-a-service platform that integrates with camera systems to enhance workplace safety. The company's technology focuses on identifying direct threats and provides data-driven insights and reports that facilitate a continuous feedback loop. This approach enables various industries to automate safety measures and improve operational efficiency. AI-Prime's commitment to creating safer working environments positions it as a key player in the field of industrial security solutions.

Philm

Series B in 2018
Philm is a photo and video editing application developed by Yoyo Visual World Co., Ltd., which focuses on transforming ordinary videos and photos into artistic creations. Launched in October 2016, this innovative app features real-time art video filters and motion-tracking stickers, allowing users to easily convert video clips and images into animated artworks. By leveraging advanced AI and deep learning technologies, Philm captures the essence of various artistic styles, applying them to users' content with a live preview feature. Additionally, the app includes dynamic emoji stickers that adjust in size and orientation based on the objects they are attached to. Philm aims to enhance user creativity and engagement by providing a seamless way to craft personalized art-styled videos, and it collaborates with corporate and intellectual property brands to commercialize its offerings. Based in China, Philm stands out as a pioneering platform in the realm of real-time video editing.

The Makers

Series B in 2018
The Makers is a technology-focused media content provider based in China, specializing in the sharing of innovative solutions and ideas. The company operates a platform dedicated to technology and innovation, and it aims to lead the trend in robotics competition and entertainment through its flagship show, King of Bots. By combining media and technology, The Makers fosters engagement and enthusiasm for robotics, positioning itself as a key player in the evolving landscape of tech-driven entertainment.

CastBox

Series B in 2018
Founded in 2016, CastBox operates a global spoken audio platform offering personalized recommendations for listeners of podcasts, on-demand radio, and audiobooks. Its application is accessible across mobile devices, desktops, and smart home devices, with offices in Beijing, Hong Kong, and San Francisco.

Infervision

Series B in 2018
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

BingoBox

Series B in 2018
BingoBox is an innovative convenience store in China that operates with a high degree of automation, aiming to reduce operational costs and eliminate the need for on-site staff. The stores are stocked with everyday essentials, including snacks and beverages, catering to late-night shoppers. Customers gain access by scanning a QR code and can make payments through mobile platforms. Utilizing advanced technologies such as artificial intelligence, computer vision, and smart shelf systems, BingoBox effectively tracks inventory and ensures that all items are paid for before leaving the store. While the stores are not entirely automated, as remote customer service and daily restocking by staff are still in place, BingoBox represents a significant advancement in the retail sector by streamlining the shopping experience and enhancing convenience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.